أعرض تسجيلة المادة بشكل مبسط

dc.creator Mahoney M
dc.creator Symons A
dc.creator Kimmel S
dc.date 2003
dc.date.accessioned 2013-05-30T11:25:44Z
dc.date.available 2013-05-30T11:25:44Z
dc.date.issued 2013-05-30
dc.identifier http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2003;volume=49;issue=2;spage=141;epage=7;aulast=Mahoney
dc.identifier http://www.doaj.org/doaj?func=openurl&genre=article&issn=00223859&date=2003&volume=49&issue=2&spage=141
dc.identifier.uri http://koha.mediu.edu.my:8181/jspui/handle/123456789/4590
dc.description Smallpox virus has gained considerable attention as a potential bioterrorism agent. Recommendations for smallpox (vaccinia) vaccination presume a low risk for use of smallpox as a terrorist biological agent and vaccination is currently recommended for selected groups of individuals such as health care workers, public health authorities, and emergency/rescue workers, among others. Information about adverse reactions to the smallpox vaccine is based upon studies completed during the 1950s and 1960s. The prevalence of various diseases has changed over the last four decades and new disease entities have been described during this period. The smallpox vaccination may be contra-indicated in many of these conditions. This has made pre-screening of potential vaccines necessary. It is believed that at present, the risks of vaccine-associated complications far outweigh the potential benefits of vaccination in the general population.
dc.publisher Medknow Publications
dc.source Journal of Postgraduate Medicine
dc.title Smallpox: clinical highlights and considerations for vaccination.


الملفات في هذه المادة

الملفات الحجم الصيغة عرض

لا توجد أي ملفات مرتبطة بهذه المادة.

هذه المادة تبدو في المجموعات التالية:

أعرض تسجيلة المادة بشكل مبسط